Literature DB >> 22922421

Large granular lymphocytic leukemia: a treatable form of refractory celiac disease.

Georgia Malamut1, Bertrand Meresse, Virginie Verkarre, Sophie Kaltenbach, Nicolas Montcuquet, Jean-Paul Duong Van Huyen, Céline Callens, Julien Lenglet, Gabriel Rahmi, Elia Samaha, Brigitte Ranque, Elizabeth Macintyre, Isabelle Radford-Weiss, Olivier Hermine, Nadine Cerf-Bensussan, Christophe Cellier.   

Abstract

Large granular lymphocyte leukemia (LGL) is characterized by clonal expansion of CD3+ T cells or CD3(-) natural killer cells and frequently is associated with autoimmune diseases. We describe 2 patients with celiac disease who no longer responded to gluten-free diets after they developed T-cell LGL, with intestinal localization of malignant lymphocytes. Flow cytometry phenotyping of isolated intestinal intraepithelial and lamina propria cells eliminated type II refractory celiac disease, identifying large-sized CD8(+)CD57(+) T cells. Treatment with a combination of cyclosporine and methotrexate restored the patients' sensitivity to gluten-free diets. LGL therefore might be a cause of refractory celiac disease that is sensitive to immunosuppressive therapy.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922421     DOI: 10.1053/j.gastro.2012.08.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  CD103+ γδ T cell large granular lymphocytosis in a patient with refractory celiac disease: a diagnostic enigma.

Authors:  Sreejesh Sreedharanunni; Neelam Varma; Man Updesh Singh Sachdeva; Kirti Gupta; Rekha Pai; Rakesh Kochhar; Pankaj Malhotra; Subhash Varma
Journal:  Int J Hematol       Date:  2015-01-31       Impact factor: 2.490

2.  Large granular lymphocyte cells and immune dysregulation diseases - the chicken or the egg?

Authors:  Anton W Langerak; Jorn L J C Assmann
Journal:  Haematologica       Date:  2018-02       Impact factor: 9.941

Review 3.  Genomics of LGL leukemia and select other rare leukemia/lymphomas.

Authors:  Katharine B Moosic; Umadevi Paila; Kristine C Olson; Karolina Dziewulska; T Tiffany Wang; Jeffrey C Xing; Aakrosh Ratan; David J Feith; Thomas P Loughran; Thomas L Olson
Journal:  Best Pract Res Clin Haematol       Date:  2019-06-06       Impact factor: 3.020

4.  Persistent γδ T large granular lymphocytosis in a patient with refractory pure red cell aplasia, celiac disease, and chronic hepatitis B infection.

Authors:  S Sreedharanunni; Mus Sachdeva; G Prakash; R Das
Journal:  J Postgrad Med       Date:  2016 Jan-Mar       Impact factor: 1.476

Review 5.  Recent advances in celiac disease and refractory celiac disease.

Authors:  Georgia Malamut; Sascha Cording; Nadine Cerf-Bensussan
Journal:  F1000Res       Date:  2019-06-26

6.  Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.

Authors:  Ikram Nasr; Iman Nasr; Carl Beyers; Fuju Chang; Suzanne Donnelly; Paul J Ciclitira
Journal:  Nutrients       Date:  2015-12-01       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.